These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23603643)
1. National trends in emergency department use of urinalysis, complete blood count, and blood culture for fever without a source among children aged 2 to 24 months in the pneumococcal conjugate vaccine 7 era. Simon AE; Lukacs SL; Mendola P Pediatr Emerg Care; 2013 May; 29(5):560-7. PubMed ID: 23603643 [TBL] [Abstract][Full Text] [Related]
2. Predictors of occult bacteremia in young febrile children in the era of heptavalent pneumococcal conjugated vaccine. Mintegi S; Benito J; Sanchez J; Azkunaga B; Iturralde I; Garcia S Eur J Emerg Med; 2009 Aug; 16(4):199-205. PubMed ID: 19593900 [TBL] [Abstract][Full Text] [Related]
3. Emergency department laboratory evaluations of fever without source in children aged 3 to 36 months. Simon AE; Lukacs SL; Mendola P Pediatrics; 2011 Dec; 128(6):e1368-75. PubMed ID: 22106081 [TBL] [Abstract][Full Text] [Related]
4. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department. Sard B; Bailey MC; Vinci R Pediatr Emerg Care; 2006 May; 22(5):295-300. PubMed ID: 16714955 [TBL] [Abstract][Full Text] [Related]
5. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine. Carstairs KL; Tanen DA; Johnson AS; Kailes SB; Riffenburgh RH Ann Emerg Med; 2007 Jun; 49(6):772-7. PubMed ID: 17337092 [TBL] [Abstract][Full Text] [Related]
6. Impact of the pneumococcal conjugate vaccine in the management of highly febrile children aged 6 to 24 months in an emergency department. Mintegi S; Benito J; González M; Astobiza E; Sanchez J; Santiago M Pediatr Emerg Care; 2006 Aug; 22(8):566-9. PubMed ID: 16912624 [TBL] [Abstract][Full Text] [Related]
7. Emergency department epidemiology of pneumococcal bacteremia in children since the institution of widespread PCV7 vaccination. Mistry RD; Wedin T; Balamuth F; McGowan KL; Ellison AM; Nelson KA; McLoughlin RJ; Alpern ER J Emerg Med; 2013 Dec; 45(6):813-20. PubMed ID: 23992851 [TBL] [Abstract][Full Text] [Related]
8. Management of febrile children in the conjugate pneumococcal vaccine era. Gabriel ME; Aiuto L; Kohn N; Barone SR Clin Pediatr (Phila); 2004; 43(1):75-82. PubMed ID: 14968896 [TBL] [Abstract][Full Text] [Related]
9. Bacteremia in feverish children presenting to the emergency department: a retrospective study and literature review. Bressan S; Berlese P; Mion T; Masiero S; Cavallaro A; Da Dalt L Acta Paediatr; 2012 Mar; 101(3):271-7. PubMed ID: 21950707 [TBL] [Abstract][Full Text] [Related]
10. Febrile seizures with leukocytosis as a predictor for occult bacteremia. Ogawa E; Shoji K; Kamidani S; Miyairi I Pediatr Int; 2019 Jun; 61(6):578-582. PubMed ID: 30980459 [TBL] [Abstract][Full Text] [Related]
11. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center. Stoll ML; Rubin LG Arch Pediatr Adolesc Med; 2004 Jul; 158(7):671-5. PubMed ID: 15237067 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of febrile children without localising signs after pneumococcal conjugate vaccine. Waddle E; Jhaveri R Arch Dis Child; 2009 Feb; 94(2):144-7. PubMed ID: 18539684 [TBL] [Abstract][Full Text] [Related]
13. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain. Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875 [TBL] [Abstract][Full Text] [Related]
15. Paediatric community-acquired bacteraemia, pneumococcal invasive disease and antibiotic resistance fell after the pneumococcal conjugate vaccine was introduced. Berger Y; Adler A; Ariel T; Rokney A; Averbuch D; Grisaru-Soen G Acta Paediatr; 2019 Jul; 108(7):1321-1328. PubMed ID: 30506762 [TBL] [Abstract][Full Text] [Related]
16. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979 [TBL] [Abstract][Full Text] [Related]
17. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Lee GM; Fleisher GR; Harper MB Pediatrics; 2001 Oct; 108(4):835-44. PubMed ID: 11581433 [TBL] [Abstract][Full Text] [Related]
18. Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain. Hernández-Bou S; Gómez B; Mintegi S; García-García JJ; Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1449-1455. PubMed ID: 29736610 [TBL] [Abstract][Full Text] [Related]
19. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Grijalva CG; Poehling KA; Nuorti JP; Zhu Y; Martin SW; Edwards KM; Griffin MR Pediatrics; 2006 Sep; 118(3):865-73. PubMed ID: 16950975 [TBL] [Abstract][Full Text] [Related]
20. Occult Bacteremia: Should We Look for the Needle in the Haystack? Baram N; Megged O; Weiser G Isr Med Assoc J; 2016 Nov; 18(11):649-651. PubMed ID: 28466611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]